Cargando…

Correction: Circulating Levels of Human Salusin-β, a Potent Hemodynamic and Atherogenesis Regulator

Detalles Bibliográficos
Autores principales:	Fujimoto, Kazumi, Hayashi, Akinori, Kamata, Yuji, Ogawa, Akifumi, Watanabe, Takuya, Ichikawa, Raishi, Iso, Yoshitaka, Koba, Shinji, Kobayashi, Youichi, Koyama, Takatoshi, Shichiri, Masayoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841072/ http://dx.doi.org/10.1371/annotation/f628c1d6-4bee-4725-b434-690f169a7849

Ejemplares similares

Circulating Levels of Human salusin-β,a Potent Hemodynamic and Atherogenesis Regulator
por: Fujimoto, Kazumi, et al.
Publicado: (2013)

Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide
por: Fujimoto, Kazumi, et al.
Publicado: (2017)

Levels of albuminuria and risk of developing macroalbuminuria in type 2 diabetes: historical cohort study
por: Chida, Shoma, et al.
Publicado: (2016)

Robust increase in glucagon secretion after oral protein intake, but not after glucose or lipid intake in Japanese people without diabetes
por: Ichikawa, Raishi, et al.
Publicado: (2023)

Salusin-β as a powerful endogenous antidipsogenic neuropeptide
por: Suzuki-Kemuriyama, Noriko, et al.
Publicado: (2016)

Salusins: Potential Use as a Biomarker for Atherosclerotic Cardiovascular Diseases
por: Sato, Kengo, et al.
Publicado: (2013)

Identification of the salusin-β receptor using proteoliposomes embedded with endogenous membrane proteins
por: Shichiri, Masayoshi, et al.
Publicado: (2018)

Methionine sulfoxides in serum proteins as potential clinical biomarkers of oxidative stress
por: Suzuki, Satoko, et al.
Publicado: (2016)

Molecular form and concentration of serum α(2)-macroglobulin in diabetes
por: Yoshino, Sonomi, et al.
Publicado: (2019)

Serum salusin-α and salusin-β levels in patients with psoriatic arthritis
por: Kobak, Senol, et al.
Publicado: (2022)

Salusin-β is superior to salusin-α as a marker for evaluating coronary atherosclerosis
por: Wang, Yuxue, et al.
Publicado: (2020)

New Indices for Predicting Glycaemic Variability
por: Ogawa, Akifumi, et al.
Publicado: (2012)

Salusin beta, atherosclerosis, and coronary slow flow
por: Akıncı, Sinan, et al.
Publicado: (2020)

Effects of Two Types of Moderate- and High-Intensity Interval Training on Serum Salusin-α and Salusin-β Levels and Lipid Profile in Women with Overweight/Obesity
por: Nazari, Maryam, et al.
Publicado: (2020)

GIP_HUMAN[22–51] is a new proatherogenic peptide identified by native plasma peptidomics
por: Masaki, Tsuguto, et al.
Publicado: (2021)

Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy
por: Zhao, Ming-Xia, et al.
Publicado: (2017)

Relationship of serum salusin beta levels with coronary slow flow
por: Akyüz, Aydın, et al.
Publicado: (2019)

A New Marker for Determining Cardiovascular Risk: Salusin Alpha
por: Yılmaz, Emre, et al.
Publicado: (2022)

Salusin-β Not Salusin-α Promotes Vascular Inflammation in ApoE-Deficient Mice via the I-κBα/NF-κB Pathway
por: Zhou, Cheng-Hua, et al.
Publicado: (2014)

Salusin-β, but Not Salusin-α, Promotes Human Umbilical Vein Endothelial Cell Inflammation via the p38 MAPK/JNK-NF-κB Pathway
por: Zhou, Cheng-Hua, et al.
Publicado: (2014)

Short-term Change in Resting Energy Expenditure and Body Compositions in Therapeutic Process for Graves' Disease
por: Hayashi, Akinori, et al.
Publicado: (2020)

Exosomes and Atherogenesis
por: Lin, Bingbing, et al.
Publicado: (2021)

Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population?
por: Kołakowska, Urszula, et al.
Publicado: (2014)

The Clinical Significance of Salusins in Systemic Sclerosis—A Cross-Sectional Study
por: Nowaczyk, Joanna, et al.
Publicado: (2023)

Activation of Coagulation by Lenalidomide-Based Regimens for the Treatment of Multiple Myeloma
por: Isozumi, Yu, et al.
Publicado: (2013)

Atherogenesis: Initiating Factors
por: Waters, L. L.
Publicado: (1974)

Platelets in Inflammation and Atherogenesis
por: Nording, Henry M., et al.
Publicado: (2015)

Roles of Macrophages in Atherogenesis
por: Farahi, Lia, et al.
Publicado: (2021)

Overexpression of Salusin-α Inhibits Vascular Intimal Hyperplasia in an Atherosclerotic Rabbit Model
por: Qian, Kun, et al.
Publicado: (2018)

Silencing salusin-β attenuates cardiovascular remodeling and hypertension in spontaneously hypertensive rats
por: Ren, Xing-Sheng, et al.
Publicado: (2017)

Potent Vasoconstrictor Kisspeptin‐10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist
por: Sato, Kengo, et al.
Publicado: (2017)

Roles of Bone-Marrow-Derived Cells and Inflammatory Cytokines in Neointimal Hyperplasia after Vascular Injury
por: Shoji, Makoto, et al.
Publicado: (2014)

Central blockade of salusin β attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats
por: Li, Hong-Bao, et al.
Publicado: (2015)

Targeted Delivery of Salusin‐α Into Rabbit Carotid Arterial Endothelium Using SonoVue
por: Wang, Yuxue, et al.
Publicado: (2021)

Methotrexate in Atherogenesis and Cholesterol Metabolism
por: Coomes, Eric, et al.
Publicado: (2011)

The Importance of the Plasma Membrane in Atherogenesis
por: Kotlyarov, Stanislav, et al.
Publicado: (2022)

Telomere Length: Implications for Atherogenesis
por: Yin, Hao, et al.
Publicado: (2023)

Low serum 25-hydroxyvitamin D level is associated with obesity and atherogenesis in adolescent boys
por: Naganuma, Junko, et al.
Publicado: (2022)

The role of adropin, salusin-α, netrin-1, and nesfatin-1 in endometriosis and their association with insulin resistance
por: Akbaba, Eren, et al.
Publicado: (2021)

Infectious Agents Are Not Necessary for Murine Atherogenesis
por: Wright, Samuel D., et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_ma6708j37ji481f60fcu27rpnl